![]() |
市場調查報告書
商品編碼
1894883
生物醫學與資訊通信技術融合市場:按技術、解決方案和地區劃分(2025-2030 年)Biomedical and ICT Convergence Market by Technology, Solution and Region 2025 - 2030 |
||||||
本報告評估了資訊通信技術 (ICT) 產業與生物醫學科學技術的融合。報告總結了生物醫學領域的發展趨勢,並從互聯醫療設備等資訊通信技術創新角度分析了資訊通信技術行業。報告還預測了物聯網互聯醫療設備(獨立式、穿戴式和植入式)的發展趨勢,並評估了有望受益於各種資訊科技和通訊技術的生物醫學產品、服務和解決方案的前景。
生物醫學領域是一個高度交叉的領域,融合了生物學、化學和物理學等多種自然科學,旨在增進我們對人類健康的理解。 其根本目標是開發創新幹預措施、療法和醫療技術,以改善臨床實踐。
順應這一趨勢,Mind Commerce 將資訊通信技術 (ICT) 行業視為涵蓋廣泛通訊和計算基礎設施的領域,並專注於數據管理中硬體和軟體的無縫整合。該領域通常被歸類於更廣泛的科技、媒體和電信 (TMT) 領域,TMT 指的是數位系統、廣播媒體和資料傳輸的整合。這些產業共同構成了現代數位商務、內容分發和互動應用的基礎。
生物醫學科學與資訊通信技術 (ICT) 的有意融合,代表著醫療保健和科技行業的突破性轉變,創造了一個以跨學科創新為特徵的高增長領域。除了根除疾病和預防慢性病等傳統目標之外,這兩個領域的整合旨在提高醫療程序的精確度。
透過利用數位工具,醫療保健提供者可以提高整體護理效率,同時簡化醫療服務的物流。 這種協同作用不僅使醫療服務更加高效,而且更加便捷和系統化,將患者體驗從碎片化轉變為連貫的、數據驅動的過程。
應對現代醫療保健的經濟挑戰或許是推動這項技術整合的最迫切因素。醫療保健成本持續高於通貨膨脹率,威脅全球醫療保健系統的可持續性。因此,在減輕治療經濟負擔的同時改善患者療效至關重要。
這包括優化營運支出,並降低與研發相關的巨額成本。在藥物發現和疫苗開發等領域,精準醫療(根據每個人的基因譜量身定制治療方案)的應用至關重要。這減少了通常與 "一刀切" 的醫療模式相關的資源浪費。
物聯網 (IoT) 是資訊通信技術 (ICT) 在臨床環境中實際應用的典範。支援物聯網的設備可以即時監測患者對各種治療的反應。這種細緻的監測在引入新的或未經檢驗的醫療方法時至關重要。
相關的例子包括疫苗接種和表觀遺傳學研究的進展。表觀遺傳學研究的是環境因素和行為如何影響基因表達,而不改變DNA序列本身。雖然像疫苗接種這樣的醫療幹預措施旨在預防疾病,但資訊通信技術(ICT)工具可以識別出少數人群,他們獨特的表觀遺傳標記可能會無意中影響其生理結果。
在這個融合領域中最具活力的子領域之一是無線IP行動和穿戴式技術的廣泛應用。結合先進的植入式感測器,這些技術能夠以前所未有的水平進行持續的生理監測,這在醫學領域尚屬首次。
這些互聯設備可作為臨床決策支援和自動化治療管理的綜合平台。透過向醫療保健專業人員提供持續不斷的高精度資料流,它們能夠幫助做出更明智的診斷並快速調整治療方案。
最終,這些數位工具在被動式和預防式醫療保健框架中都將同樣有效。 在前者中,它們能夠透過自動胰島素滴定來管理糖尿病等慢性疾病。在後者中,它們能夠優化疫苗接種計劃並改進疫苗配方,從而在疾病發生之前就進行預防。
因此,資訊通信技術與生物醫學的融合有望帶來雙重益處:一方面,透過降低成本和開發新型療法來穩定醫療經濟,另一方面,透過數據驅動的個人化醫療來提升全球公共衛生水平。
This report evaluates the market for convergence between the Information and Communications Technology (ICT) industry and biomedical science and technologies. The report evaluates the latter and analyzes the former in terms of ICT innovation such as connected medical devices. In addition to forecasts for IoT connected healthcare devices (standalone, wearable, and implantable), the report also assesses the outlook for various biomedical products, services, and solutions poised to benefit from various IT and telecom technologies.
The field of biomedicine represents a sophisticated intersection of various natural science disciplines, including biology, chemistry, and physics, synthesized to advance our understanding of human health. It is fundamentally dedicated to the creation of innovative interventions, therapeutic modalities, and medical technologies that enhance clinical practice.
Parallel to this dynamic, Mind Commerce sees the Information and Communications Technology (ICT) sector encompassing the vast infrastructure of telecommunications and computing, focusing on the seamless integration of hardware and software to manage data. This sector is often categorized within the broader TMT framework-Technology, Media, and Telecommunications, which accounts for the convergence of digital systems, broadcast media, and data transmission. Together, these industries form the backbone of modern digital commerce, content distribution, and interactive applications.
The deliberate convergence of biomedical science and ICT signifies a monumental shift for both the healthcare and technology industries, creating a high-growth area characterized by cross-disciplinary innovation. Beyond the traditional objectives of eradicating diseases and preventing chronic ailments, the marriage of these fields is designed to enhance the precision of medical treatments.
By leveraging digital tools, providers can improve the overall efficacy of care while streamlining the logistics of healthcare delivery. This synergy ensures that medical services are not only more effective but also more accessible and systematically organized, transforming the patient experience from a fragmented process into a cohesive, data-driven journey.
Addressing the economic challenges of modern medicine is perhaps the most urgent driver of this technological integration. Healthcare expenditures consistently outpace general inflation, threatening the sustainability of global health systems. Consequently, there is a critical need to improve patient outcomes while simultaneously reducing the financial burden of care.
This involves optimizing operational expenditures and mitigating the immense costs associated with research and development. In areas like pharmaceutical drug discovery and vaccine development, the application of precision medicine, which tailors treatment to individual genetic profiles, is essential for reducing the wasted resources often found in "one-size-fits-all" medical models.
The practical application of ICT in clinical settings often manifests through the Internet of Things (IoT), where enabled devices monitor patient responses to various procedures in real time. Such granular monitoring is vital when introducing new or unproven healthcare modalities.
A pertinent example involves vaccine administration and the emerging study of epigenetics, which examines how environmental factors and behaviors influence gene expression without altering the underlying DNA sequence. While a medical intervention like a vaccine is designed with the singular, positive intent of disease inoculation, ICT tools can help identify the minute subset of the population that might experience unintended physiological consequences due to their unique epigenetic markers.
One of the most dynamic subsectors of this convergence is the proliferation of wireless, IP-enabled handheld devices and wearable technologies. These tools, alongside sophisticated implantable sensors, offer a level of continuous physiological monitoring that was previously impossible in the history of medical science.
These connected devices serve as comprehensive platforms for clinical decision support and automated treatment administration. By providing clinicians with a constant stream of high-fidelity data, these technologies allow for more informed diagnoses and more rapid adjustments to treatment plans.
Ultimately, these digital tools are equally effective across both reactive and proactive medical frameworks. In reactive care, they can manage chronic conditions like diabetes through automated insulin modification; in proactive care, they can optimize vaccine schedules and formulations to prevent illness before it occurs.
The integration of ICT and biomedicine is therefore expected to yield a dual benefit: it will stabilize the economics of healthcare by lowering costs and uncovering new revenue streams through novel treatments, while simultaneously elevating the standards of global public health through personalized, data-centric care.